The historical rank and industry rank for EirGenix's OCF Margin % or its related term are showing as below:
TPE:6589'
s OCF Margin % Range Over the Past 10 Years
Min: -164.99 Med: -35 Max: 29.65
Current: 29.65
During the past 13 years, the highest OCF Margin % of EirGenix was 29.65%. The lowest was -164.99%. And the median was -35.00%.
TPE:6589's OCF Margin % is ranked better than 89.27% of 951
companies
in the Biotechnology industry
Industry Median: -64.23
vs TPE:6589: 29.65
EirGenix OCF Margin % Related Terms
EirGenix OCF Margin % Historical Data
* Premium members only.
The historical data trend for EirGenix's OCF Margin % can be seen below:
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
TPE:6589 vs VRTX, REGN, ALNY: OCF Margin % Comparison
For the Biotechnology subindustry, EirGenix's OCF Margin %, along with its competitors' market caps and OCF Margin % data, can be viewed below:
* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.
EirGenix OCF Margin % vs Biotechnology Industry
For the Biotechnology industry and Healthcare sector, EirGenix's OCF Margin % distribution charts can be found below:
* The bar in red indicates where EirGenix's OCF Margin % falls into.
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
EirGenix (TPE:6589) has a OCF Margin % of 168.72% as of Dec. 2025. OCF Margin is the ratio of Cash Flow from Operations to Total Revenue. View historical data on EirGenix and its competitors. According to the industry distribution chart, EirGenix ranks #102 out of 951 companies in the Biotechnology industry, placing it in the top 10.7%.
Is EirGenix's OCF Margin % too high?
EirGenix's current OCF Margin % is 168.72%. Based on the distribution chart, EirGenix ranks #102 out of 951 companies in the Biotechnology industry, which is in the top quartile — a strong position relative to peers. Overall, EirGenix has a GF Score™ of 58/100 and is considered Possible Value Trap, reflecting its overall financial health beyond just this single metric.
How does EirGenix's OCF Margin % compare to VRTX and REGN?
According to the Biotechnology industry distribution chart, EirGenix ranks #102 out of 951 companies for OCF Margin %. This places EirGenix in the top 11% of its industry — outperforming the majority of peers. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good OCF Margin % for a Biotechnology company?
A good OCF Margin % depends on the Biotechnology industry context. However, OCF Margin % should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high OCF Margin % mean?
A high OCF Margin % can signal that a stock is expensive relative to its fundamentals. OCF Margin is the ratio of Cash Flow from Operations to Total Revenue. View historical data on EirGenix and its competitors. EirGenix's current OCF Margin % is 168.72%. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is EirGenix stock overvalued right now?
Based on GuruFocus' analysis, EirGenix (TPE:6589) is currently considered Possible Value Trap. The stock's GF Value™ is NT$92.26, compared to a current price of NT$49.70 — trading 46.1% below its estimated fair value. The current OCF Margin % is 168.72%. EirGenix's overall GF Score™ is 58/100 with 6 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is OCF Margin % calculated?
OCF Margin % is calculated from a company's financial statements. For EirGenix (TPE:6589), the current OCF Margin % is 168.72% as of Dec. 2025. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.
Is EirGenix (TPE:6589) Overvalued in 2026?
Based on GuruFocus' analysis, EirGenix stock appears to be undervalued.
The current stock price of NT$49.70 is trading 46.1% below its estimated GF Value™ of NT$92.26.
GuruFocus considers EirGenix to be Possible Value Trap.
Key valuation signals for TPE:6589:
OCF Margin %: 168.72%
GF Value™: NT$92.26 vs. price of NT$49.70 (46.1% below fair value)
No single metric tells the full story. See the TPE:6589 stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.
EirGenix Inc is engaged in the research and development of biosimilars and new drugs, as well as biopharmaceutical contract development and manufacturing services, which included cell line construction platforms, process development platforms, analytical science and protein identification. Its products include CRM197 CARRIER PROTEIN, PRODUCT PIPELINE, COVID-19 ANTIGEN RAPID TEST. The revenue is derived from biopharmaceutical contract development and manufacturing services, sales of authorization and cooperative development, and sales of goods. Geographically, it operates in Japan, Taiwan, USA and Canada, Mainland China, Hong Kong, and Macao, and Europe, Others.
58GF Score
Get the complete analysis for TPE:6589
OCF Margin % is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.
Quick Browse
Personalize
Premium Gurus 
Create New Portfolio
TPE:6589 has been successfully added to your 
